VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,575,764 | +43.6% | 207,199 | +60.7% | 0.28% | +40.1% |
| Q2 2023 | $3,883,349 | +66.4% | 128,971 | +78.7% | 0.20% | +51.9% |
| Q1 2023 | $2,334,169 | -29.9% | 72,153 | -37.9% | 0.13% | -36.4% |
| Q4 2022 | $3,331,285 | -10.0% | 116,235 | -24.3% | 0.21% | -25.6% |
| Q3 2022 | $3,702,000 | +27.8% | 153,468 | +45.1% | 0.28% | +10.2% |
| Q2 2022 | $2,896,000 | -19.3% | 105,784 | +13.0% | 0.26% | -6.2% |
| Q1 2022 | $3,589,000 | +31.1% | 93,592 | +9.5% | 0.27% | +34.7% |
| Q4 2021 | $2,738,000 | +25.0% | 85,473 | +15.0% | 0.20% | +13.5% |
| Q3 2021 | $2,191,000 | -26.5% | 74,340 | -15.3% | 0.18% | -5.8% |
| Q2 2021 | $2,981,000 | +36.1% | 87,727 | +30.1% | 0.19% | +19.6% |
| Q1 2021 | $2,191,000 | -4.2% | 67,425 | +6.2% | 0.16% | -16.8% |
| Q4 2020 | $2,286,000 | +1.4% | 63,467 | +10.2% | 0.19% | -15.9% |
| Q3 2020 | $2,255,000 | +130.1% | 57,592 | +115.5% | 0.23% | +68.7% |
| Q2 2020 | $980,000 | -21.7% | 26,723 | -50.8% | 0.13% | -25.6% |
| Q1 2020 | $1,251,000 | -19.9% | 54,306 | +1.8% | 0.18% | -2.7% |
| Q4 2019 | $1,562,000 | +6.1% | 53,330 | -3.2% | 0.18% | -7.5% |
| Q3 2019 | $1,472,000 | +2.6% | 55,113 | -1.8% | 0.20% | -3.8% |
| Q2 2019 | $1,435,000 | +14.1% | 56,148 | +0.1% | 0.21% | -1.0% |
| Q1 2019 | $1,258,000 | +12.3% | 56,100 | +5.6% | 0.21% | -2.8% |
| Q4 2018 | $1,120,000 | +278.4% | 53,112 | +231.9% | 0.22% | +237.5% |
| Q3 2018 | $296,000 | -11.4% | 16,001 | +6.9% | 0.06% | -24.7% |
| Q2 2018 | $334,000 | +4.7% | 14,966 | +4.2% | 0.08% | -1.2% |
| Q1 2018 | $319,000 | -2.4% | 14,366 | +2.8% | 0.09% | -1.1% |
| Q4 2017 | $327,000 | +1.2% | 13,976 | +2.8% | 0.09% | -37.0% |
| Q3 2017 | $323,000 | +1694.4% | 13,601 | +4.1% | 0.14% | +1433.3% |
| Q2 2017 | $18,000 | -60.0% | 13,066 | +587.7% | 0.01% | -70.0% |
| Q1 2017 | $45,000 | +9.8% | 1,900 | 0.0% | 0.03% | -3.2% |
| Q4 2016 | $41,000 | – | 1,900 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |